|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
CHEMOKINES
From INSERM U362, Institut Gustave Roussy, Villejuif
Cedex, France; INSERM U461, Faculté de Pharmacie-Paris Sud,
Chatenay-Malabry, France; Transfusion Medicine, University of Ulm, Ulm,
Germany; and INSERM U429, Hôpital Necker Enfants Malades, Paris
Cedex 15, France.
In studies aimed at further characterizing the cellular
immunodeficiency of the Wiskott-Aldrich syndrome (WAS), we found that T
lymphocytes from WAS patients display abnormal chemotaxis in response
to the T-cell chemoattractant stromal cell-derived factor (SDF)-1. The
Wiskott- Aldrich syndrome protein (WASP), together with the Rho
family GTPase Cdc42, control stimulus-induced actin cytoskeleton
rearrangements that are involved in cell motility. Because WASP is an
effector of Cdc42, we further studied how Cdc42 and WASP are involved
in SDF-1-induced chemotaxis of T lymphocytes. We provide here direct
evidence that SDF-1 activates Cdc42. We then specifically investigated
the role of the interaction between Cdc42 and WASP in SDF-1-responsive
cells. This was achieved by abrogating this interaction with a
recombinant polypeptide (TAT-CRIB), comprising the Cdc42/Rac
interactive binding (CRIB) domain of WASP and a human immunodeficiency
virus-TAT peptide that renders the fusion protein cell-permeant. This
TAT-CRIB protein was shown to bind specifically to Cdc42-GTP and to
inhibit the chemotactic response of a T-cell line to SDF-1. Altogether,
these data demonstrate that Cdc42-WASP interaction is critical for
SDF-1-induced chemotaxis of T cells.
(Blood. 2001;97:33-38) The Wiskott-Aldrich syndrome (WAS) is an X-linked
hereditary disease associated with mutations in the
WASP gene and characterized by thrombocytopenia, with
small platelet size, eczema, and increased susceptibility to
infections.1 Recent reports have helped to understand some
of the function of the WAS protein (WASP), and many findings are
consistent with the hypothesis that WASP has an important role in
controlling the actin cytoskeleton. Indeed, WASP contains, at its
C-terminal region, verprolin and cofilin homology domains2
found in other cytoskeletal-associated proteins and, also, a Ccd42/Rac
interactive binding (CRIB) domain that binds to the small GTPase
Cdc42.3-5 It was also recently demonstrated that
WASP could interact with the actin-related protein (Arp2/3) complex to
induce actin polymerization.6-11 Actin cytoskeleton rearrangements are essential for cell motility, and WASP-deficient cells display impaired migration. Indeed, chemotaxis was shown to be
deficient in WAS; in several cell lineages including macrophages and
monocytes in response to MCP-1, MIP-1 In recent years, it has become clear that the dynamics of actin
cytoskeleton is controlled in part by the Rho family GTPases. Cdc42,
Rac, and Rho have been shown to regulate cortical actin polymerization
events leading respectively to filopodia, lamellipodia, or stress
fibers formation.17 These functions are mediated through effector proteins that, upon binding to the small GTPases, either become activated or undergo conformational changes that allow for new
protein interactions to occur. Well-characterized effectors of Cdc42
that contain a CRIB domain include the PAK family serine kinases18-20 and WASP.5 We therefore
investigated whether the interaction between WASP and Cdc42 could be
involved in the SDF-1-induced chemotaxis of T lymphocytes.
Cell preparation and migration assays
Migration assays were performed using 5 µm (mononuclear cells) or 8 µm (CEM cells) pore filters (Transwell, 24-well cell clusters; Costar, Cambridge, MA). Cell suspensions (2.5 × 105
cells in a 100 µL volume) were placed into the upper chamber, whereas
600 µL of medium with or without recombinant human SDF-1 (300 ng/mL)
(R & D Systems; Minneapolis, MN) was introduced in the lower chamber.
The chambers were incubated for 1 hour at 37°C in 5% CO2
and 95% air. The cells in the upper and in the bottom chamber were
recovered separately in the same volume for counting. For human
mononuclear cells, the different cell fractions were then labeled with
a phycoerythrin-anti-CD3 monoclonal antibody and analyzed by flow
cytometry. Percentage of migrating cells was determined as follows:
[number of cells migrating (lower chamber)/ total number of cells
(cells in the lower chamber + remaining cells in the upper
chamber)]. All assays were done in triplicate.
Plasmid constructs and TAT-CRIB protein purification
Affinity precipitation of Cdc42-GTP Immobilized GST-CRIB was mixed with CEM T-cell lysates at 4°C for 1 hour. After washing, Cdc42-GTP was extracted in 2 × sample buffer and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by transfer to polyvinylidene fluoride (PVDF) membranes. Bound Cdc42 was detected using a polyclonal antibody against Cdc42,24 and immunoreactive bands were visualized using an enhanced chemiluminescence (ECL) detection system (Amersham Pharmacia).Immunoprecipitation and kinase assay of PAK CEM cells were lysed in 40 mM HEPES (pH 7.4), 1% Nonidet P-40, 100 mM NaCl, 1 mM ethylenediaminetetraacetic acid, 25 mM NaF, 1 mM sodium orthovanadate, 10 µg/mL aprotinin, and 100 µg/mL leupeptin. PAKs were immunoprecipitated at 4°C for 2 hours with anti-PAK-2 (Santa Cruz, CA) or anti-PAK-4 antibodies (a gift from A. Abo, Onyx Pharmaceuticals, Richmond, CA). The immune complexes were recovered using protein G-coupled agarose. PAK activity was determined in an in vitro kinase assay by mixing 30 µL of immune complexes with 30 µL of a phosphorylation mixture containing (final concentration) 40 mM HEPES (pH 7.4), 100 mM NaCl, 10 mM MgCl2, 1 mM MnCl2, 20 µM adenosine triphosphate, and 185 kBq (5 µCi) [ -32P] adenosine triphosphate together
with 5 µg myelin basic protein as a substrate, at 30°C for 20 minutes as described.25 The reaction was stopped by
boiling in 2 × sample buffer and analyzed by SDS-PAGE followed by autoradiography.
Western blot anti-WASP Cells were lysed in 50 mM Tris, 0.5% Nonidet P-40, 250 mM NaCl, 5 mM ethylenediaminetetraacetic acid, and a protease inhibitor cocktail (Boehringer Mannheim, Germany). Lysates were extracted in 2 × sample buffer. Forty-microgram proteins were separated by SDS-PAGE followed by transfer to PVDF membranes. Actin and WASP were detected using a monoclonal anti-WASP antibody (a gift from D. Nelson, National Institutes of Health, Bethesda, MD) and a monoclonal anti- actin
antibody (Sigma, St Louis, MO), respectively, and immunoreactive bands
were visualized using an ECL detection system.
T lymphocytes from WAS patients display abnormal chemotaxis in response to SDF-1 Freshly isolated PBMCs from WAS patients were tested for their chemotactic response to SDF-1 in a Transwell migration assay in parallel with PBMCs from normal donors. CD3+ T cells from 5 of 6 patients showed a dramatic reduction in chemotaxis (Figure 1). However, migration was not completely abolished because 2.7% to 7.5% of CD3+ cells were recovered in the lower chamber as opposed to 0.4% in the absence of SDF-1. In patient no. 6, T-lymphocyte migration was partly reduced to about 70% of the control. Interestingly, the WASP gene mutation in this patient leads to a stop codon at position 494, likely resulting in expression of a partly functional protein. This was confirmed by a Western blot analysis of T-cell lysates from patients no. 6 and 2 as compared with T cells of control (Figure 2). Indeed, in patient no. 2, whose gene mutation leads to a stop codon at position 83, no WASP protein could be detected in lymphocytes while, in patient no. 6, WASP protein appeared to be expressed although at a much lower level than in control lymphocytes.
These results thus suggest that WASP is required for T-cell chemotaxis in response to SDF-1. SDF-1 activates Cdc42 in a T-cell line Because WASP is a known effector of Cdc42,3-5 we hypothesized that SDF-1 signaling involves a Cdc42-WASP pathway and that WASP functions as a Cdc42 effector in SDF-1-induced T-cell chemotaxis. This hypothesis implies that SDF-1 activates Cdc42. This was demonstrated using a GST fusion protein containing the CRIB motif of WASP that specifically binds the GTP-bound form of Cdc42. This protein was used to pull down activated Cdc42 from extracts of resting or SDF-1-stimulated CEM cells, a human T-cell line that migrates in response to SDF-1. As shown in Figure 3A, cell stimulation with SDF-1 induced a marked increase in activated Cdc42 after 30 seconds that reached a maximum after 2 minutes. In addition, we showed that SDF-1 also activates the Cdc42 downstream effector kinases PAK-2 and PAK-4 (Figure 3B). Of note, the kinetics of activation was slightly different for PAK-2 and PAK-4, peaking at 5 minutes for PAK-2 and at 10 to 20 minutes for PAK-4. It is unclear why these kinetics do not closely parallel that of Cdc42 activation.
The interaction between Cdc42 and CRIB-containing protein(s) is needed for SDF-1-induced chemotaxis in a T-cell line To specifically investigate the interaction between Cdc42 and CRIB-containing protein(s), we designed a peptide that can be introduced into unmodified cells and directly antagonize this interaction. A fusion protein was constructed containing an extended CRIB domain of WASP, with high-affinity binding to activated Cdc42,26 fused to the human immunodeficiency virus (HIV)-TAT protein transduction domain.23 As a control, the same protein bearing mutations at 5 conserved residues that are critical for the interaction of CRIB with Cdc4227,28 was produced (Figure 4a). In vitro interaction experiments confirmed that TAT-CRIB associates specifically with GTP-loaded Cdc42, as opposed to GDP-Cdc42 or Rac, and that this association is completely abolished by the amino acid substitutions introduced in TAT-mutCRIB (Figure 4B).
To set the conditions for entry of the fusion protein into cells,
preliminary experiments using TAT-CRIB fused to a green fluorescent
protein were performed. The intracellular concentration of the protein,
as detected by fluorescence-activated cell sorter analysis, peaked at 2 hours of incubation (not shown). Therefore, CEM cells were incubated
with either TAT-CRIB or TAT-mutCRIB for 2 hours before being tested for
SDF-1-induced migration. As shown in Figure
5, TAT-CRIB did inhibit SDF-1-induced
migration in a dose-dependent manner, whereas TAT-mutCRIB had no
significant effect. A 50% migration inhibition was obtained when cells
were incubated with about 75 µg/mL TAT-CRIB. At higher TAT-CRIB
concentrations, a 25% residual migration was observed, indicating that
migration was not completely inhibited.
TAT-CRIB does not inhibit actin polymerization but inhibits PAK-2 kinase activity To test whether disrupting Cdc42/CRIB interaction also affected SDF1-induced actin polymerization,29 CEM cells that had been preincubated with TAT-CRIB or not were stained for F-actin and analyzed by cytofluorimetry. As shown in Figure 6A, TAT-CRIB, when used at a concentration that blocked cell migration, did not modify the F-actin content in resting cells or its increase in SDF-1-stimulated cells.
Because the PAK family kinases are implicated in actin polymerization,20,30,31 we investigated the effect of TAT-CRIB on PAK kinase activation in an in vitro kinase assay. Cell treatment with TAT-CRIB resulted in significant inhibition of PAK-2 kinase activity (Figure 6B). In contrast, the kinase activity of PAK-4 was not modified by cell treatment with TAT-CRIB (Figure 6B).
Although the structure of WASP and its implication in cytoskeleton regulation are well described, the exact mechanism by which abnormal or absent WASP in lymphocytes leads to immunodeficiency is not fully understood. It has been proposed that WAS may be related in part to cell trafficking alterations.32 Although impaired chemotaxis has already been described in other lineages, it is the first time that abnormal chemotaxis is reported in WAS T cells, a relevant finding in the context of an immunodeficiency. Indeed, we found that SDF-1-induced chemotaxis of T cells from 5 of 6 patients was dramatically reduced. We found also that migration was slightly impaired in one patient whose gene mutation leads to reduced WASP expression. Moreover, we found that abnormal T-cell chemotaxis in these patients did correlate with the severity of the disease as assessed by clinical scores measuring immunodeficiency, infections, and autoimmune manifestations. Indeed, patients no. 1 to 5 displayed a severe clinical score (score 5 in 4 cases and score 4 in 1 case) while patient no. 6 displayed a score 2 with a minor X-linked thrombocytopenia associated with mild eczema.1 These data, which have to be confirmed in a larger series of patients, suggest that abnormal T-cell locomotion could be critical in the outcome of immunodeficiency in this disease. These results also suggest that WASP is required for T-cell chemotaxis in response to SDF-1. WASP is a known effector of Cdc42.3-5 A variety of cell stimuli lead to activation (GTP loading) of Cdc42, which then switches to an activated conformation allowing its interaction with CRIB domain-containing proteins such as WASP or the PAK family kinases.18,20,33 These effector proteins then trigger signaling pathways that control cytoskeleton rearrangements leading to filopodia formation.17 We thus hypothesized that SDF-1 signaling involves a Cdc42-WASP pathway and that WASP functions as a Cdc42 effector in SDF-1-induced T-cell chemotaxis. In support of this hypothesis, we first demonstrated, using a direct biochemical approach, that SDF-1 activates Cdc42. Thus, on one hand, the patient studies reported above indicate that WASP is required for SDF-1-induced chemotaxis and, on the other hand, we have shown that SDF-1 activates Cdc42. We therefore investigated specifically whether the interaction between Cdc42 and CRIB-containing protein(s) was involved in SDF-1 signaling. For this purpose, the HIV-TAT polybasic transduction domain was used to introduce into otherwise unmodified cells a CRIB peptide that directly antagonizes this interaction. As a control, we designed a TAT-mutCRIB peptide that was shown not to bind Cdc42-GTP. That TAT-CRIB interacts with GTP-Cdc42 while TAT-mutCRIB does not indicates that the inhibition of migration observed in the presence of TAT-CRIB is the consequence of TAT-CRIB binding to GTP-Cdc42 and preventing Cdc42/CRIB interaction with endogenous effectors. These data, together with the demonstration that WASP is needed for SDF-1-induced migration, lead to the conclusion that the interaction between Cdc42 and WASP is required for SDF-1-induced chemotaxis in T cells. That TAT-CRIB peptide did not inhibit SDF-1-induced actin polymerization suggests that actin polymerization can be regulated independently of the Cdc42-WASP pathway. It is of interest that in studying a limited number of WAS patients (not shown), SDF-1-induced actin polymerization was found not to be consistently abnormal. This finding is in complete agreement with those of Rengan et al, who recently reported that actin polymerization was normal in WAS hematopoietic lineages.34 Because the PAK family kinases have also been reported to play a role in actin polymerization20,30,31 and because we demonstrated that kinase activity of both proteins was increased by SDF-1 stimulation, the effect of TAT-CRIB on PAK kinase activation was investigated in an in vitro kinase assay. Cell treatment with TAT-CRIB resulted in significant inhibition of PAK-2 kinase activity. This result is consistent with TAT-CRIB inhibiting the ability of Cdc42-GTP to interact with its effectors, because PAK-2 activation is known to depend on the interaction of Cdc42-GTP with the PAK CRIB domain.18,19 In contrast, the kinase activity of PAK-4 was not modified by cell treatment with TAT-CRIB. This was not unexpected because, while Cdc42 may regulate the subcellular localization of PAK-4, PAK-4 kinase activity has been shown to be independent of its interaction with Cdc42.20 It is thus possible that the normal kinase activity of PAK-4 in TAT-CRIB-treated cells could account for normal SDF-1-induced actin polymerization. This hypothesis does not, however, exclude that other pathways, eg, those regulated by Rac or Rho, may contribute to SDF-1-induced actin polymerization. Biologic effects of SDF-1 are mediated by the 7 transmembrane domains, G-protein-coupled CXCR4 receptor.35,36 SDF-1 has been shown to activate several signaling pathways, including phosphoinositide 3-kinase, mitogen-activated protein kinase, protein kinase C, and tyrosine phosphorylation of components of focal adhesion complex.37-40 Our results provide direct evidence that, in addition to these pathways, SDF-1 activates the small GTPase Cdc42 and its effectors. Furthermore, our direct approach emphasizes the critical role of the interaction between Cdc42 and WASP in a pathway controlling a physiologic function in normal cells. The role of Cdc42 in chemotaxis has been previously suggested by the use of dominant negative (N17) Cdc42 in CSF-1-induced chemotaxis of monocytic cells.41 However, GTPase's dominant negative mutants are thought to sequester exchange factors, thus preventing the activation of GTPases. In addition, because Cdc42 and Rac share several exchange factors, dominant negative mutant of Cdc42 could lead to blocking Rac as well. In contrast, the approach used here, introducing a cell-permeant CRIB motif of WASP, does not prevent Cdc42 or Rac activation nor, presumably, Cdc42 interactions with potential effectors that do not contain a CRIB domain. In addition, the CRIB-containing sequence of WASP used here has no significant interaction with recombinant Rac protein, as shown in Figure 4, nor with endogenous Rac as assessed by GST pull-down experiments (not shown). As a result, our approach focuses on the role of Cdc42 interaction with its effectors in chemotaxis rather than on the role of Cdc42 activation and demonstrates that the interaction between Cdc42 and WASP is required for SDF-1-induced chemotaxis. Because Cdc42-WASP interaction was found dispensable for SDF-1-induced actin polymerization, it can be hypothesized that this interaction is necessary to give directionality to cell movement but is not essential for cell locomotion itself. Indeed, Cdc42 is known to play a critical role in cell polarization in budding yeast42 during fibroblast migration43 or antigen presentation in lymphocytes.44 Moreover, it has been demonstrated that macrophages injected with the dominant negative N17Cdc42 were able to migrate but did not polarize in the direction of a CSF-1 gradient.41 Similarly, macrophages from WAS patients were shown to display abnormal chemotaxis whereas their speed of random migration was conserved.13 Accordingly, random movement may explain the residual migration observed in WASP-deficient lymphocytes (Figure 1) or in CEM cells where Cdc42-WASP interaction had been disrupted (Figure 6A). The pathogenesis of the immunodeficiency in WAS is not completely understood. It has been suggested that altered cytoskeleton function may affect antigen presentation and dendritic cell migration.14 Following the observation that small GTPases of the Rho family, particularly Cdc42, regulate cell apoptosis,45 it has also been proposed that increased apoptosis in lymphocytes may play a critical role in the disease.34,46 Finally, it is possible that the defect in T-cell migration reported here may participate in the immunodeficiency observed in WAS by impairing the capacity of T lymphocytes to home properly to lymphoid organs.
We thank Drs S. Dowdy, P. Chavrier, T. Azuma, A. Abo, and D. Nelson for valuable reagents; G. Tchernia, N. Wulffraadt, and S. Blanche for patient blood samples; J. P. Hossle and A. Wechsler for mutation analysis of patient no. 3; and A. Vazquez and D. Duménil for helpful discussions.
Submitted May 18, 2000; accepted August 18, 2000.
Supported by INSERM and in part by Association pour la Recherche contre le Cancer (grant no. 5608 to J.B. and no. 9728 to N.D.), Ligue Nationale contre le Cancer, and by E.C. grant QLGICT199901090/RA015F. J.L.Z. received an INSERM fellowship contributed by the Conseil Regional d'Ile-de-France followed by a grant from Fondation pour la Recherche Médicale.
E.H. and J.L.Z. contributed equally to this work.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Jacques Bertoglio, INSERM U461, Faculté de Pharmacie-Paris Sud, 5, Rue Jean-Baptiste Clément, 92296 Chatenay-Malabry, France; e-mail: j.bertoglio{at}cep.u-psud.fr.
1. Ochs H. The Wiskott-Aldrich syndrome. Springer Semin Immunopathol. 1998;19:435-458[CrossRef][Medline] [Order article via Infotrieve]. 2. Miki H, Miura K, Takenawa T. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 1996;15:5326-5335[Medline] [Order article via Infotrieve]. 3. Aspenström P, Lindberg U, Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol. 1996;6:70-75[CrossRef][Medline] [Order article via Infotrieve].
4.
Kolluri R, Tolias K, Carpenter C, Rosen F, Kirchhausen T.
Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42.
Proc Natl Acad Sci U S A.
1996;93:5615-5618 5. Symons M, Derry J, Karlak B, et al. WiskottAldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 1996;84:723-734[CrossRef][Medline] [Order article via Infotrieve]. 6. Higgs HN, Blanchoin L, Pollard TD. Influence of the C terminus of Wiskott-Aldrich syndrome protein (WASp) and the Arp2/3 complex on actin polymerization. Biochemistry. 1999;38:15212-15222[CrossRef][Medline] [Order article via Infotrieve].
7.
Higgs HN, Pollard TD.
Regulation of actin polymerization by Arp2/3 complex and WASP/Scar proteins.
J Biol Chem.
1999;274:32531-32534 8. Yarar D, To W, Abo A, Welch MD. The Wiskott-Aldrich syndrome protein directs actin-based motility by stimulating actin nucleation with the Arp2/3 complex. Curr Biol. 1999;9:555-558[CrossRef][Medline] [Order article via Infotrieve]. 9. Rohatgi R, Ma L, Miki H, et al. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell. 1999;97:221-231[CrossRef][Medline] [Order article via Infotrieve].
10.
Machesky LM, Mullins RD, Higgs HN, et al.
Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex.
Proc Natl Acad Sci U S A.
1999;96:3739-3744 11. Machesky LM, Insall RH. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol. 1998;8:1347-1356[CrossRef][Medline] [Order article via Infotrieve].
12.
Badolato R, Sozzani S, Malacarne F, et al.
Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine.
J Immunol.
1998;161:1026-1033 13. Zicha D, Allen W, Brickell P, et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol. 1998;101:659-665[CrossRef][Medline] [Order article via Infotrieve]. 14. Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR, Thrasher AJ. Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur J Immunol. 1998;28:3259-3267[CrossRef][Medline] [Order article via Infotrieve].
15.
Haddad E, Cramer E, Riviere C, et al.
The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.
Blood.
1999;94:509-518 16. Van Epps DE, El-Naggar A, Ochs HD. Abnormalities of lymphocyte locomotion in immunodeficiency disease. Clin Exp Immunol. 1983;53:678-688[Medline] [Order article via Infotrieve].
17.
Hall A.
Rho GTPases and the actin cytoskeleton.
Science.
1998;279:509-514 18. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature. 1994;367:40-46[CrossRef][Medline] [Order article via Infotrieve]. 19. Martin GA, Bollag G, McCormick F, Abo A. A novel serine kinase activated by rac1/CDC42Hs-dependent autophosphorylation is related to PAK65 and STE20 [published erratum appears in EMBO J. 1995;14:4385]. EMBO J. 1995;14:1970-1978[Medline] [Order article via Infotrieve]. 20. Abo A, Qu J, Cammarano MS, et al. PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J. 1998;17:6527-6540[CrossRef][Medline] [Order article via Infotrieve]. 21. Remold-O'Donnell E, Cooley J, Shcherbina A, et al. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients. J Immunol. 1997;158:4021-4025[Abstract].
22.
Zhu Q, Watanabe C, Liu T, et al.
Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype.
Blood.
1997;90:2680-2689 23. Nagahara H, Vocero-Akbani A, Snyder E, et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med. 1998;4:1449-1452[CrossRef][Medline] [Order article via Infotrieve]. 24. Lang P, Gesbert F, Thiberge JM, et al. Characterization of a monoclonal antibody specific for the Ras-related GTP-binding protein Rho A. Biochem Biophys Res Commun. 1993;196:1522-1528[CrossRef][Medline] [Order article via Infotrieve].
25.
Tang Y, Yu J, Field J.
Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts.
Mol Cell Biol.
1999;19:1881-1891
26.
Rudolph MG, Bayer P, Abo A, Kuhlmann J, Vetter IR, Wittinghofer A.
The Cdc42/Rac interactive binding region motif of the Wiskott Aldrich syndrome protein (WASP) is necessary but not sufficient for tight binding to Cdc42 and structure formation.
J Biol Chem.
1998;273:18067-18076 27. Mott HR, Owen D, Nietlispach D, et al. Structure of the small G protein Cdc42 bound to the GTPase-binding domain of ACK. Nature. 1999;399:384-388[CrossRef][Medline] [Order article via Infotrieve]. 28. Abdul-Manan N, Aghazadeh B, Liu GA, et al. Structure of Cdc42 in complex with the GTPase-binding domain of the "Wiskott-Aldrich syndrome" protein. Nature. 1999;399:379-383[CrossRef][Medline] [Order article via Infotrieve].
29.
Bleul C, Fuhlbrigge R, Casasnovas J, Aiuti A, Springer T.
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor (SDF-1).
J Exp Med.
1996;184:1101-1109
30.
Dharmawardhane S, Sanders LC, Martin SS, Daniels RH, Bokoch GM.
Localization of p21-activated kinase 1 (PAK1) to pinocytic vesicles and cortical actin structures in stimulated cells.
J Cell Biol.
1997;138:1265-1278 31. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr Biol. 1997;7:202-210. 32. Thrasher AJ, Jones GE, Kinnon C, Brickell PM, Katz DR. Is Wiskott-Aldrich syndrome a cell trafficking disorder? Immunol Today. 1998;19:537-539[CrossRef][Medline] [Order article via Infotrieve].
33.
Burbelo PD, Drechsel D, Hall A.
A conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases.
J Biol Chem.
1995;270:29071-29074
34.
Rengan R, Ochs HD, Sweet LI, et al.
Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells.
Blood.
2000;95:1283-1292 35. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382:829-833[CrossRef][Medline] [Order article via Infotrieve]. 36. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 [published erratum appears in Nature. 1996;384:288]. Nature. 1996;382:833-835[CrossRef][Medline] [Order article via Infotrieve].
37.
Ganju RK, Brubaker SA, Meyer J, et al.
The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.
J Biol Chem.
1998;273:23169-23175
38.
Vicente-Manzanares M, Rey M, Jones DR, et al.
Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis.
J Immunol.
1999;163:4001-4012
39.
Wang JF, Park IW, Groopman JE.
Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C.
Blood.
2000;95:2505-2513
40.
Sotsios Y, Whittaker GC, Westwick J, Ward SG.
The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes.
J Immunol.
1999;163:5954-5963
41.
Allen WE, Zicha D, Ridley AJ, Jones GE.
A role for Cdc42 in macrophage chemotaxis.
J Cell Biol.
1998;141:1147-1157
42.
Johnson DI, Pringle JR.
Molecular characterization of CDC42, a Saccharomyces cerevisiae gene involved in the development of cell polarity.
J Cell Biol.
1990;111:143-152
43.
Nobes CD, Hall A.
Rho GTPases control polarity, protrusion, and adhesion during cell movement.
J Cell Biol.
1999;144:1235-1244
44.
Stowers L, Yelon D, Berg LJ, Chant J.
Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase CDC42.
Proc Natl Acad Sci U S A.
1995;92:5027-5031 45. Chuang TH, Hahn KM, Lee JD, Danley DE, Bokoch GM. The small GTPase Cdc42 initiates an apoptotic signaling pathway in Jurkat T lymphocytes. Mol Biol Cell. 1997;8:1687-1698[Abstract].
46.
Rawlings SL, Crooks GM, Bockstoce D, Barsky LW, Parkman R, Weinberg KI.
Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression.
Blood.
1999;94:3872-3882
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  R. Cheung, M. Malik, V. Ravyn, B. Tomkowicz, A. Ptasznik, and R. G. Collman An arrestin-dependent multi-kinase signaling complex mediates MIP-1{beta}/CCL4 signaling and chemotaxis of primary human macrophages J. Leukoc. Biol., October 1, 2009; 86(4): 833 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bosticardo, F. Marangoni, A. Aiuti, A. Villa, and M. Grazia Roncarolo Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome Blood, June 18, 2009; 113(25): 6288 - 6295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Le Bras, M. Massaad, S. Koduru, L. Kumar, M. K. Oyoshi, J. Hartwig, and R. S. Geha WIP is critical for T cell responsiveness to IL-2 PNAS, May 5, 2009; 106(18): 7519 - 7524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Notarangelo and R. Badolato Leukocyte trafficking in primary immunodeficiencies J. Leukoc. Biol., March 1, 2009; 85(3): 335 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Bai, H. Hayasaka, M. Kobayashi, W. Li, Z. Guo, M. H. Jang, A. Kondo, B.-i. Choi, Y. Iwakura, and M. Miyasaka CXC Chemokine Ligand 12 Promotes CCR7-Dependent Naive T Cell Trafficking to Lymph Nodes and Peyer's Patches J. Immunol., February 1, 2009; 182(3): 1287 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Abouzahr-Rifai, M. Hasmim, H. Boukerche, J. Hamelin, B. Janji, A. Jalil, C. Kieda, F. Mami-Chouaib, J. Bertoglio, and S. Chouaib Resistance of Tumor Cells to Cytolytic T Lymphocytes Involves Rho-GTPases and Focal Adhesion Kinase Activation J. Biol. Chem., November 14, 2008; 283(46): 31665 - 31672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Wojciak-Stothard New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling Postgrad. Med. J., July 1, 2008; 84(993): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sturge, S. K. Todd, G. Kogianni, A. McCarthy, and C. M. Isacke Mannose receptor regulation of macrophage cell migration J. Leukoc. Biol., September 1, 2007; 82(3): 585 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Caracino, C. Jones, M. Compton, and C. L. Saxe III The N-Terminus of Dictyostelium Scar Interacts with Abi and HSPC300 and Is Essential for Proper Regulation and Function Mol. Biol. Cell, May 1, 2007; 18(5): 1609 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Huang and J. K. Burkhardt T-cell-receptor-dependent actin regulatory mechanisms J. Cell Sci., March 1, 2007; 120(5): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sabri, A. Foudi, S. Boukour, B. Franc, S. Charrier, M. Jandrot-Perrus, R. W. Farndale, A. Jalil, M. P. Blundell, E. M. Cramer, et al. Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment Blood, July 1, 2006; 108(1): 134 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Gallego, M. A. de la Fuente, I. M. Anton, S. Snapper, R. Fuhlbrigge, and R. S. Geha WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1{alpha} Int. Immunol., February 1, 2006; 18(2): 221 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Snapper, P. Meelu, D. Nguyen, B. M. Stockton, P. Bozza, F. W. Alt, F. S. Rosen, U. H. von Andrian, and C. Klein WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo J. Leukoc. Biol., June 1, 2005; 77(6): 993 - 998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. de Noronha, S. Hardy, J. Sinclair, M. P. Blundell, J. Strid, O. Schulz, J. Zwirner, G. E. Jones, D. R. Katz, C. Kinnon, et al. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein Blood, February 15, 2005; 105(4): 1590 - 1597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Westerberg, M. Larsson, S. J. Hardy, C. Fernandez, A. J. Thrasher, and E. Severinson Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response Blood, February 1, 2005; 105(3): 1144 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Burns, G. O. Cory, W. Vainchenker, and A. J. Thrasher Mechanisms of WASp-mediated hematologic and immunologic disease Blood, December 1, 2004; 104(12): 3454 - 3462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Chernyavsky, J. Arredondo, L. M. Marubio, and S. A. Grando Differential regulation of keratinocyte chemokinesis and chemotaxis through distinct nicotinic receptor subtypes J. Cell Sci., November 1, 2004; 117(23): 5665 - 5679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Diebold, B. Fowler, J. Lu, M. C. Dinauer, and G. M. Bokoch Antagonistic Cross-talk between Rac and Cdc42 GTPases Regulates Generation of Reactive Oxygen Species J. Biol. Chem., July 2, 2004; 279(27): 28136 - 28142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Spiegel, O. Kollet, A. Peled, L. Abel, A. Nagler, B. Bielorai, G. Rechavi, J. Vormoor, and T. Lapidot Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling Blood, April 15, 2004; 103(8): 2900 - 2907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lacout, E. Haddad, S. Sabri, F. Svinarchouk, L. Garcon, C. Capron, A. Foudi, R. Mzali, S. B. Snapper, F. Louache, et al. A defect in hematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome Blood, August 15, 2003; 102(4): 1282 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ratner, M. P. Piechocki, and A. Galy Role of Rho-family GTPase Cdc42 in polarized expression of lymphocyte appendages J. Leukoc. Biol., June 1, 2003; 73(6): 830 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Klein, D. Nguyen, C.-H. Liu, A. Mizoguchi, A. K. Bhan, H. Miki, T. Takenawa, F. S. Rosen, F. W. Alt, R. C. Mulligan, et al. Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice Blood, March 15, 2003; 101(6): 2159 - 2166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Srinivasan, F. Wang, S. Glavas, A. Ott, F. Hofmann, K. Aktories, D. Kalman, and H. R. Bourne Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis J. Cell Biol., February 3, 2003; 160(3): 375 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Samstag, S. M. Eibert, M. Klemke, and G. H. Wabnitz Actin cytoskeletal dynamics in T lymphocyte activation and migration J. Leukoc. Biol., January 1, 2003; 73(1): 30 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Falet, K. M. Hoffmeister, R. Neujahr, and J. H. Hartwig Normal Arp2/3 complex activation in platelets lacking WASp Blood, August 28, 2002; 100(6): 2113 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Dunussi-Joannopoulos, K. Zuberek, K. Runyon, R. G. Hawley, A. Wong, J. Erickson, S. Herrmann, and J. P. Leonard Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses Blood, August 13, 2002; 100(5): 1551 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ticchioni, C. Charvet, N. Noraz, L. Lamy, M. Steinberg, A. Bernard, and M. Deckert Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration Blood, May 1, 2002; 99(9): 3111 - 3118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nishita, H. Aizawa, and K. Mizuno Stromal Cell-Derived Factor 1{alpha} Activates LIM Kinase 1 and Induces Cofilin Phosphorylation for T-Cell Chemotaxis Mol. Cell. Biol., February 1, 2002; 22(3): 774 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Vicente-Manzanares, J. R. Cabrero, M. Rey, M. Perez-Martinez, A. Ursa, K. Itoh, and F. Sanchez-Madrid A Role for the Rho-p160 Rho Coiled-Coil Kinase Axis in the Chemokine Stromal Cell-Derived Factor-1{alpha}-Induced Lymphocyte Actomyosin and Microtubular Organization and Chemotaxis J. Immunol., January 1, 2002; 168(1): 400 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Ottoson, J. T. Pribila, A. S. H. Chan, and Y. Shimizu Cutting Edge: T Cell Migration Regulated by CXCR4 Chemokine Receptor Signaling to ZAP-70 Tyrosine Kinase J. Immunol., August 15, 2001; 167(4): 1857 - 1861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Worthylake, S. Lemoine, J. M. Watson, and K. Burridge RhoA is required for monocyte tail retraction during transendothelial migration J. Cell Biol., July 9, 2001; 154(1): 147 - 160. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
, or CSF-1 
), patients; (
), normal donors.
-),
Pak-2;
(-
-),
Pak-4.
) for 2 hours. Cells were then left unstimulated or were
stimulated with 500 ng/mL SDF-1 for 5 (PAK-2) or 20 minutes (PAK-4) and
lysed. The lysates were immunoprecipitated with anti-PAK-2 or
anti-PAK-4, and PAK activity was determined by in vitro kinase assay.
Data shown represent mean + SE of 4 (PAK-2) or 3 (PAK-4) independent
experiments. Representative autoradiograms are shown in insets.